In addition, recent studies have shown that SHIP1 is negatively regulated by BCR-ABL1 in both chronic myeloid leukemia (CML) and Philadelphia (Ph)-chromosome-positive B-ALL cells. Here, INPP5D is linked to chronic myelogenous leukemia, BCR-ABL1 positive.